Keyword: Novartis

What does it take for a company to attract millennials? An inspiring culture—and jeans, according to Novartis CEO Vas Narasimhan.

The government is riled up about drug prices and promising to drive them down, but a CMS report shows retail drug spending grew just 0.4% last year.

Following an EpiPen generic launch by Teva, Novartis' Sandoz has released its launch plans for epinephrine alternative Symjepi.

Of 31 drugs the Chinese government listed for a pilot bidding program, multinational pharmas landed only two contracts.

With blockbuster Xolair aging, Novartis is looking to usher in a successor to protect its sales. And it got one step closer this week.

Months ago, GSK said it would gin up some cash by selling its Horlicks drinks brand, and now it's come through with a £3.1 billion sale to Unilever.

Gilead and Novartis are working to ramp up launches of their CAR-T drugs, and both companies are hoping longer-term data will help do the trick.

The Novartis CEO said he was "completely blindsided" by news of the $1.2 million payment to Michael Cohen after just three months on the job.

Among small batch of price increases for the pharma giant was a 1.5% increase on superstar cancer drug Keytruda and 6% on HPV shot Gardasil.

Astellas will likely soon be joined by Daiichi in relapsed/refractory FLT3-mutated AML, and both have eyes on Novartis' Rydapt.